NCT04946968 2025-06-11
Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers
National Cancer Centre, Singapore
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT00768664 2021-02-09
Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer
Pfizer
Phase 2 Completed
NCT01116843 2015-07-10
Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment
University Health Network, Toronto
Phase 1/2 Completed
NCT01484847 2015-07-10
A Study of PF-00299804 When Given Through a Feeding Tube in Locally Advanced Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto
Phase NA Completed
NCT01449201 2014-09-30
PF-00299804 in Patients With Head and Neck Squamous Cell Carcinoma
Yonsei University
Phase 2 Completed